Evidence map›Paper›PMID 31425676›Full record

ReviewArchives of biochemistry and biophysics2019

HO-1 overexpression and underexpression: Clinical implications.

George S Drummond, Jeffrey Baum, Menachem Greenberg, David Lewis, Nader G Abraham

Open access · hybridAbstract readReview
In one paragraph

Review in Archives of biochemistry and biophysics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 1 synthesis or guideline pooled it, 135 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Therapeutic Effects of ProbioticFood science & nutrition · 2026
    Article
  4. Article
  5. Article
  6. Heme oxygenase-1 and malaria pathogenesis.Frontiers in immunology · 2026
    Review
  7. Article
  8. Review
  9. Anti-Inflammatory Effect of 21Food science & nutrition · 2025
    Article
  10. Review
  11. The Small Molecule Compound Eupalinolide B Alleviates Neuropathic Pain by Regulating the USP7/Keap1/Nrf2 Pathway.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Article
  12. Article
  13. Article
  14. Protective effect ofAnatomy & cell biology · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

George S DrummondDepartment of Pharmacology, New York Medical College, Valhalla, NY, 10595, USA.
Jeffrey BaumDepartment of Medicine, New York Medical College, Valhalla, NY, 10595, USA; Department of Pharmacology, New York Medical College, Valhalla, NY, 10595, USA.
Menachem GreenbergDepartment of Medicine, New York Medical College, Valhalla, NY, 10595, USA; Department of Pharmacology, New York Medical College, Valhalla, NY, 10595, USA.
David LewisDepartment of Medicine, New York Medical College, Valhalla, NY, 10595, USA; Department of Pharmacology, New York Medical College, Valhalla, NY, 10595, USA.
Nader G AbrahamDepartment of Medicine, New York Medical College, Valhalla, NY, 10595, USA; Department of Pharmacology, New York Medical College, Valhalla, NY, 10595, USA; Joan C. Edwards School of Medicine, Marshall University, Huntington, WV, 25701, USA. Electronic address: nader_abraham@nymc.edu.
New York Medical College · US

Funding

HEME OXYGENASE REGULATION OF EICOSANOID BIOSYNTHESISR01DK056601 · NIDDK · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI ABRAHAM, NADER G. · 2001 to 2013
$4.4M
Adipocyte EET-PGC1alpha-HO-1 in Obesity-driven HypertensionR56HL139561 · NHLBI · NEW YORK MEDICAL COLLEGE · PI ABRAHAM, NADER G. · 2018 to 2018
$503k
NHLBI NIH HHS R56 HL139561NIDDK NIH HHS R01 DK056601
6 · The paper itself

Abstract

In this review we examine the effects of both over- and under-production of heme oxygenase-1 (HO-1) and HO activity on a broad spectrum of biological systems and on vascular disease. In a few instances e.g., neonatal jaundice, overproduction of HO-1 and increased HO activity results in elevated levels of bilirubin requiring clinical intervention with inhibitors of HO activity. In contrast HO-1 levels and HO activity are low in obesity and the HO system responds to mitigate the deleterious effects of oxidative stress through increased levels of bilirubin (anti-inflammatory) and CO (anti-apoptotic) and decreased levels of heme (pro-oxidant). Site specific HO-1 overexpression diminishes adipocyte terminal differentiation and lipid accumulation of obesity mediated release of inflammatory molecules. A series of diverse strategies have been implemented that focus on increasing HO-1 and HO activity that are central to reversing the clinical complications associated with diseases including, obesity, metabolic syndrome and vascular disease.

Indexed as

Gene Expression Regulation, EnzymologicAnimalsDiseaseHemeHeme Oxygenase-1HumansSignal TransductionHemeHeme Oxygenase-1Adipocyte inflammationBilirubinFatty liverHyperbilirubinemiaHypertensionObesity

Identifiers

PMID31425676
PMCPMC6748652
OpenAlexW2968066609

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.